← All Transmedics Group, INC filings

Transmedics Group, INC Form 4 insider transactions

NASDAQ
TMDX
Transmedics Group, INC
Form 4: TransMedics Group Executive Tamer Khayal Exercises Options and Sells Shares
Tamer Khayal, Chief Commercial Officer of TransMedics Group, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
TMDX
Transmedics Group, INC
Form 4: TransMedics Group CFO Stephen Gordon Executes Stock Option and Sells Shares
Stephen Gordon, CFO of TransMedics Group, exercised stock options and sold 15,000 shares of common stock on March 4, 2024, according to a recent SEC filing.
NASDAQ
TMDX
Transmedics Group, INC
Form 4: TransMedics Group Director James Tobin Sells Shares Under 10b5-1 Trading Plan
Director James Tobin sold shares of TransMedics Group, Inc. (TMDX) on March 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
TMDX
Transmedics Group, INC
Form 4: TransMedics Group Executive Tamer Khayal Reports Acquisition of Stock and Options
Tamer Khayal, Chief Commercial Officer of TransMedics Group, reports the acquisition of restricted stock units and stock options, along with adjustments to beneficial ownership.
NASDAQ
TMDX
Transmedics Group, INC
Form 4: TransMedics Group Executive Acquires Shares and Stock Options
Nicholas Corcoran, SVP of Supply Chain and Operations at TransMedics Group, acquired shares and stock options on February 23, 2024.
NASDAQ
TMDX
Transmedics Group, INC
Form 4: TransMedics Group CFO Stephen Gordon Reports Acquisition of Shares and Stock Options
Stephen Gordon, CFO of TransMedics Group, reports the acquisition of restricted stock units and stock options.
NASDAQ
TMDX
Transmedics Group, INC
Form 4: TransMedics Group CEO Waleed Hassanein Acquires Shares and Stock Options
TransMedics Group CEO Waleed Hassanein reports acquisition of restricted stock units and stock options.